Jgp Global Gestao De Recursos Ltda. Exelixis, Inc. Transaction History

Jgp Global Gestao De Recursos Ltda.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$18.93 - $24.75 $359,158 - $469,581	-18,973 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$19.6 - $24.76 $34,456 - $43,528	1,758 Added 10.21%	18,973 $452,000
Q4 2018 Jan 23, 2019	SELL	$13.65 - $21.8 $13,950 - $22,279	-1,022 Reduced 5.6%	17,215 $339,000
Q3 2018 Oct 25, 2018	BUY	$15.87 - $22.4 $125,706 - $177,430	7,921 Added 76.78%	18,237 $323,000
Q2 2018 Aug 10, 2018	SELL	$18.56 - $22.45 $217,226 - $262,754	-11,704 Reduced 53.15%	10,316 $222,000
Q1 2018 Apr 17, 2018	BUY	$22.15 - $31.89 $44,300 - $63,780	2,000 Added 9.99%	22,020 $488,000
Q4 2017 Feb 01, 2018	SELL	$24.23 - $30.93 $48,460 - $61,860	-2,000 Reduced 9.08%	20,020 $609,000
Q3 2017 Nov 09, 2017	BUY	$23.35 - $29.24 $514,167 - $643,864	22,020	22,020 $534,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.